Arkolith/Insider Trading/ETON/Form 4

Opaleye Management Inc.

10% OwnerEton Pharmaceuticals, Inc. (ETON) · full profile →Form 4 · filed Oct 25, 2024
Net Buying
Open-Market Buys
$80K
Open-Market Sells
$0
Net Open-Market Flow
$80K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 23, 2024Buy(P)10K$7.98$80K2.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-042516) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML